Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Boris, Finkel"'
Autor:
Avi Bleich, Piter Andreyev, Yuval Melamed, Yehoshua Segev, Mahmud Naser, Rena Kurs, Craig Goodman, Boris Finkel
Publikováno v:
Journal of Nervous & Mental Disease. 195:415-420
Neurocognitive deficits are associated with chronic schizophrenia and aging. We investigated whether elderly chronic schizophrenia inpatients who also suffer from posttraumatic stress disorder (PTSD) have more severe cognitive impairment than elderly
Autor:
Kyra Kanyas, Fabio Macciardi, Bernard Lerer, Shmuel Hirschmann, Joseph Zislin, Baruch Shapira, Michael Schlafman, Ilan Modai, Boris Finkel, Yami Shapira, Adnan Hamdan, Arturo G. Lerner, Ronnen H. Segman, Osnat Karni, Uriel Heresco-Levy
Publikováno v:
American Journal of Medical Genetics. 114:310-314
Angiotensin converting enzyme (ACE) is a candidate gene for psychiatric disorders. We examined the frequency of a functional insertion/deletion (I/D) polymorphism in the 16th intron of the ACE gene (located on chromosome 17q23) in groups of patients
Autor:
Bernard Lerer, Michael Schlafman, Abe Dorevitch, A Yakir, Uriel Heresco-Levy, Ronnen H. Segman, Aida Shelevoy, T Goltser, Roi Inbar, Tal Neeman, Arturo G. Lerner, Boris Finkel
Publikováno v:
Psychopharmacology. 152:408-413
Rationale: Tardive dyskinesia (TD) is a long-term adverse effect of dopamine receptor blockers. The dopamine D3 receptor gene (DRD3) ser9gly polymorphism has been previously associated with susceptibility to TD. Serotonin receptor antagonism has been
Publikováno v:
The Israel Medical Association journal : IMAJ. 12(9)
In compliance with public health measures initiated by the Israel Ministry of Health following an outbreak of influenza, amantadine was administered to all patients in the psychogeriatric department of Lev Hasharon Mental Health Center to reduce tran
Publikováno v:
International Clinical Psychopharmacology. 16:117-119
Leukopenia and agranulocytosis are well reported and dangerous haematological side-effects associated with the use of typical and atypical antipsychotics. These potentially life-threatening phenomena have led to treatment discontinuation and the cons
Autor:
Sigalit Noam, Marc Gelkopf, Rena Kurs, Yuval Melamed, Adiel Doron, Boris Finkel, Peninah Behrbalk, Avi Bleich
Publikováno v:
The Journal of nervous and mental disease. 195(8)
In 1996, mobile polls were introduced in Israel, enabling physically and emotionally ill inpatients to vote. We surveyed the rate of participation of inpatients at Lev-Hasharon Mental Health Center in parliamentary elections, their feelings regarding
Autor:
Rael D. Strous, Dori Laub, Moshe Kotler, Irit Felsen, Boris Finkel, Yuval Melamed, Mordechai Weiss, Avraham Bleich
Publikováno v:
The American journal of psychiatry. 162(12)
Many Holocaust survivors who have both psychotic disorders and residual symptoms of posttraumatic stress disorder (PTSD) remain chronically hospitalized in psychiatric institutions. This study investigated the clinical benefits of a therapeutic proce
Publikováno v:
Harefuah. 144(5)
Psychiatric patients' coping capacity with various life situations is limited due to their mental illness. This difficulty is even more pronounced when dealing with severe physical conditions such as kidney failure, the need for dialysis and kidney t
Autor:
Gabriela Knoll, Michael Poyurovsky, Feodor Buniak, Amos Frisch, Haggai Hermesh, Elena Michaelovsky, Ilan Amir, Boris Finkel, Ronit Weizman
Publikováno v:
Neuroscience letters. 389(1)
This is the first study of a possible molecular genetic basis for schizophrenia with obsessive-compulsive disorder (OCD). We performed a case–control association study of the catechol- O -methyltransferase (COMT) Val 158 Met polymorphism in schizop
Autor:
Yuval, Melamed, Boris, Finkel, Yoram, Barak, Patricia, Zipris, Igor, Oyffe, Abraham, Weizman, Avi, Bleich
Publikováno v:
Harefuah. 144(4)
Schizophrenia is a severely limiting chronic illness. The disease is characterized by periods of psychoses, remission, and sometimes even recovery. Effective pharmacotherapy for schizophrenia began with the development of antipsychotic neuroleptics i